Stock-Based Compensation for Cencora (COR)
Stock-Based Compensation for Cencora (COR): headline value $117.69M · YoY -100.0%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
COR
Currently viewingStock-Based CompensationSwitch metric
Latest period
$117.69M
YoY change
-100.0%
5Y CAGR
-100.0%
Peak year (2024)
$148.00M
Latest annual
$0
Stock-Based Compensation history chart for Cencora (COR) from 1994 to 2025
Stock-Based Compensation history table for Cencora (COR) from 1994 to 2025
| Fiscal year | Period ended | Reported | Stock-Based Compensation | YoY |
|---|---|---|---|---|
| 2025 | $0 | -100.0% | ||
| 2024 | $148.00M | +18.8% | ||
| 2023 | $124.62M | +33.4% | ||
| 2022 | $93.40M | -6.2% | ||
| 2021 | $99.59M | +33.8% | ||
| 2020 | $74.41M | +26.4% | ||
| 2019 | $58.87M | -5.5% | ||
| 2018 | $62.32M | +0.2% | ||
| 2017 | $62.21M | -4.3% | ||
| 2016 | $64.99M | +6.6% | ||
| 2015 | $60.94M | +41.4% | ||
| 2014 | $43.11M | +18.8% | ||
| 2013 | $36.27M | +38.9% | ||
| 2012 | $26.12M | -7.9% | ||
| 2011 | $28.36M | -8.0% | ||
| 2010 | $30.84M | +13.7% | ||
| 2009 | $27.14M | — | ||
| 2008 | $0 | — | ||
| 2007 | $0 | — | ||
| 2006 | $0 | — | ||
| 2005 | $0 | — | ||
| 2004 | $0 | — | ||
| 2003 | $0 | — | ||
| 2002 | $0 | — | ||
| 2001 | $0 | — | ||
| 2000 | $0 | — | ||
| 1999 | $0 | — | ||
| 1998 | $0 | — | ||
| 1997 | $0 | — | ||
| 1996 | $0 | — | ||
| 1995 | $0 | — | ||
| 1994 | $0 | — |
Stock-Based Compensation values are taken from Cencora's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
As of the 2025 fiscal year, Cencora (COR) reported stock-based compensation of $0 – plunged 100.0% year-over-year.
Cencora stock-based compensation has contracted on net over the period, with a -100.0% compound annual growth rate over 2020–2025 (5 years).
2024 marks the peak stock-based compensation at $148.00M, with the historical low of $0 recorded in 1994.
Within Healthcare, Cencora (COR) ranks 5th among 8 peers we track. The peer median for stock-based compensation is $313.00M.
Cencora Stock-Based Compensation by Year
Cencora Stock-Based Compensation 2025: $0
Cencora stock-based compensation in 2025 was $0, plunged 100.0% below 2024.
Cencora Stock-Based Compensation 2024: $148.00M
Cencora stock-based compensation in 2024 was $148.00M, grew 18.8% from 2023. This figure represents the highest annual value in the available history.
Cencora Stock-Based Compensation 2023: $124.62M
Cencora stock-based compensation in 2023 was $124.62M, surged 33.4% from 2022.
Cencora Stock-Based Compensation 2022: $93.40M
Cencora stock-based compensation in 2022 was $93.40M, declined 6.2% below 2021.
Cencora Stock-Based Compensation 2021: $99.59M
Cencora stock-based compensation in 2021 was $99.59M.
See more financial history for Cencora (COR).
Sector peers — Stock-Based Compensation
Companies in the same sector as Cencora, ranked by their latest stock-based compensation.
| Company | Stock-Based Compensation | Sector |
|---|---|---|
| Johnson & Johnson (JNJ) | $1.35B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $971.00M | Healthcare |
| AbbVie Inc. (ABBV) | $955.00M | Healthcare |
| Eli Lilly and Company (LLY) | $626.00M | Healthcare |
| AstraZeneca PLC (AZN) | $0 | Healthcare |
| Merck & Co., Inc. (MRK) | $0 | Healthcare |
| Amgen Inc. (AMGN) | $0 | Healthcare |
| Novo Nordisk A/S (NVO) | $0 | Healthcare |
Frequently asked questions
What is Cencora's stock-based compensation?
Latest reported stock-based compensation for Cencora (COR) is $117.69M (period ending December 31, 2025).
How has Cencora stock-based compensation changed year-over-year?
Cencora (COR) stock-based compensation changed -100.0% year-over-year on the latest annual filing.
What is the long-term growth rate of Cencora stock-based compensation?
Cencora (COR) stock-based compensation compound annual growth rate is -100.0% over the most recent 5 years available.
When did Cencora stock-based compensation hit its highest annual value?
Cencora stock-based compensation reached its highest annual value of $148.00M in 2024.
What was Cencora stock-based compensation in 2024?
Cencora (COR) stock-based compensation in 2024 was $148.00M.
What was Cencora stock-based compensation in 2025?
Cencora (COR) stock-based compensation in 2025 was $0.
Metrics overview
Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.
Explore more
COR Overview
Company profile, financial tools, and key metrics
COR Revenue Counter
Earns $10,330 every second. See per minute, hour, and day.
COR Earnings Counter
Earns $51.54 per second net profit. See per minute, hour, and day.
COR Economic Scale
Exceeds Portugal's GDP. Compare with world economies.
COR What If Invested
What if you had invested $1,000? See historical returns from any date.
COR How It Makes Money
Discover visual breakdown of $325.78B in revenue — where it comes from and where it goes.
COR Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
COR Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
COR Daily Price Character
Steady · 51.0% historical win rate (green days). Streaks & record days.
COR Buybacks
0.08% TTM buyback yield. Shareholder yield & SBC comparison.
COR Stock Split History
4 splits on record. Dates, ratios, and cumulative multiple.
COR Dividend Profile
Yield: 0.74%. Safety: 6/8. See full history.
COR Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
COR Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.